A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function

Summary

To characterize the pharmacokinetics of LCI699 following a single oral dose in adult subjects with various degrees of impaired renal function.

Timeline

Start

2015-11-06

Primary completion

2016-03-21

Completion

2016-03-21

Drugs

Indications